THE CLINICAL TRIAL TO STUDY THE EFFECT OF THE DRUG RATHA AZHUTHA NIVARANI CHOORANAM IN PATIENTS HAVING HIGH BLOOD PRESSURE

EVALUATION OF RATHA AZHUTHA NIVARANI CHOORANAM FOR URATHA PITHAVATHAM(HYPERTENSION)-AN OPEN CLINICAL STUDY

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017577

Enrollment

Registered

2019-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10-I16- Hypertensive diseases

Interventions

Intervention1: RATHA AZHUTHA NIVARANI CHOORANAM: RATHA AZHUTHA NIVARANI CHOORANAM IS ADMINISTRATTED ORALLY AT THE DOSE OF 1gm TWICE A DAY ALONG WITH HONEY FOR 48 DAYS Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: BLOOD PRESSURE LEVEL ABOVE 140/90mmHg AND BELOW 180/100mmHg FATIGUE HEADACHE NAUSEA GIDDINESS SWEATING OBESITY

Exclusion criteria

Exclusion criteria: BLOOD PRESSURE LEVEL ABOVE 180/100mmHg HYPERTENSION IN PREGNANCY ASSOCIATED OTHER SECONDARY DISEASES LIKE RENAL FAILURE CCF OTHER CARDIAC PROBLEMS CHRONIC DISEASES HORMONAL DISORDERS DIABETES MELLITUS

Design outcomes

Primary

Measure	Time frame
Outcome is mainly assessed by decrease in BP to optimum levelTimepoint: Outcome is mainly assessed by decrease in BP to optimum level	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr R Thamiloviam

GOVERNMENT SIDDHA MEDICAL COLLEGE ARUMBAKKAM CHENNAI

drkkanakavalli@gmail.com9444122865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026